• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Letter to the Editor Regarding: "Cost-Effectiveness of the 13-Valent Pneumococcal Conjugate Vaccine (PCV13) Versus Lower-Valent Alternatives in Filipino Infants".

作者信息

Gomez Jorge A, Guevara Javier Nieto, Carlos Josefina C, de Castro Joanne A, Josue Donald Ray, Rodriguez Edwin

机构信息

GlaxoSmithKline, Buenos Aires, Argentina.

GlaxoSmithKline, Panama City, Panama.

出版信息

Infect Dis Ther. 2022 Aug;11(4):1757-1761. doi: 10.1007/s40121-022-00640-w. Epub 2022 May 16.

DOI:10.1007/s40121-022-00640-w
PMID:35575972
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9334464/
Abstract
摘要

相似文献

1
Letter to the Editor Regarding: "Cost-Effectiveness of the 13-Valent Pneumococcal Conjugate Vaccine (PCV13) Versus Lower-Valent Alternatives in Filipino Infants".致编辑的信：关于“13价肺炎球菌结合疫苗（PCV13）与低价位替代疫苗在菲律宾婴儿中的成本效益比较”
Infect Dis Ther. 2022 Aug;11(4):1757-1761. doi: 10.1007/s40121-022-00640-w. Epub 2022 May 16.
2
A Response to: Letter to the Editor Regarding "Cost-Effectiveness of the 13-Valent Pneumococcal Conjugate Vaccine (PCV13) Versus Lower-Valent Alternatives in Filipino Infants".对《致编辑的信：关于“13价肺炎球菌结合疫苗（PCV13）与低剂量替代疫苗在菲律宾婴儿中的成本效益”》的回应
Infect Dis Ther. 2022 Jun;11(3):1301-1303. doi: 10.1007/s40121-022-00639-3. Epub 2022 Apr 26.
3
Cost-Effectiveness of the 13-Valent Pneumococcal Conjugate Vaccine (PCV13) Versus Lower-Valent Alternatives in Filipino Infants.13价肺炎球菌结合疫苗（PCV13）与低价替代疫苗在菲律宾婴儿中的成本效益比较
Infect Dis Ther. 2021 Dec;10(4):2625-2642. doi: 10.1007/s40121-021-00538-z. Epub 2021 Sep 30.
4
Response to Gomez et al.'s Letter to the Editor Regarding: "Cost-Effectiveness of the 13-Valent Pneumococcal Conjugate Vaccine (PCV13) Versus Lower-Valent Alternatives in Filipino Infants".对戈麦斯等人就《13价肺炎球菌结合疫苗（PCV13）与低价替代疫苗在菲律宾婴儿中的成本效益》致编辑信的回复。
Infect Dis Ther. 2022 Aug;11(4):1763-1765. doi: 10.1007/s40121-022-00641-9. Epub 2022 May 16.
5
Cost-effectiveness of a national immunization program with the 13-valent pneumococcal conjugate vaccine compared with the 10-valent pneumococcal conjugate vaccine in South Korea.在韩国，13价肺炎球菌结合疫苗与10价肺炎球菌结合疫苗的国家免疫规划的成本效益比较。
Hum Vaccin Immunother. 2021 Mar 4;17(3):909-918. doi: 10.1080/21645515.2020.1796426. Epub 2020 Aug 12.
6
Cost-effectiveness analysis of replacing the 10-valent pneumococcal conjugate vaccine (PCV10) with the 13-valent pneumococcal conjugate vaccine (PCV13) in Brazil infants.在巴西婴儿中用13价肺炎球菌结合疫苗（PCV13）替代10价肺炎球菌结合疫苗（PCV10）的成本效益分析。
Hum Vaccin Immunother. 2021 Apr 3;17(4):1162-1172. doi: 10.1080/21645515.2020.1809266. Epub 2020 Sep 23.
7
Prevention of pneumococcal disease among infants and children - use of 13-valent pneumococcal conjugate vaccine and 23-valent pneumococcal polysaccharide vaccine - recommendations of the Advisory Committee on Immunization Practices (ACIP).预防婴幼儿肺炎球菌病-使用 13 价肺炎球菌结合疫苗和 23 价肺炎球菌多糖疫苗-免疫实践咨询委员会（ACIP）的建议。
MMWR Recomm Rep. 2010 Dec 10;59(RR-11):1-18.
8
Cost-effectiveness of a 10- versus 13-valent pneumococcal conjugate vaccine in Denmark and Sweden.丹麦和瑞典 10 价与 13 价肺炎球菌结合疫苗的成本效益分析。
Clin Ther. 2013 Feb;35(2):119-34. doi: 10.1016/j.clinthera.2012.12.006. Epub 2013 Jan 10.
9
Cost-effectiveness of 2 + 1 dosing of 13-valent and 10-valent pneumococcal conjugate vaccines in Canada.加拿大 13 价和 10 价肺炎球菌结合疫苗 2+1 剂量接种的成本效益。
BMC Infect Dis. 2012 Apr 24;12:101. doi: 10.1186/1471-2334-12-101.
10
Evaluation of 13-valent pneumococcal conjugate vaccine and concomitant meningococcal group C conjugate vaccine in healthy infants and toddlers in Spain.西班牙健康婴儿和幼儿中 13 价肺炎球菌结合疫苗和同时接种的脑膜炎球菌 C 群结合疫苗的评估。
Vaccine. 2013 Nov 4;31(46):5486-94. doi: 10.1016/j.vaccine.2013.06.049. Epub 2013 Sep 1.

本文引用的文献

1
Cost-Effectiveness of the 13-Valent Pneumococcal Conjugate Vaccine (PCV13) Versus Lower-Valent Alternatives in Filipino Infants.13价肺炎球菌结合疫苗（PCV13）与低价替代疫苗在菲律宾婴儿中的成本效益比较
Infect Dis Ther. 2021 Dec;10(4):2625-2642. doi: 10.1007/s40121-021-00538-z. Epub 2021 Sep 30.
2
Trends in all-cause pneumonia and otitis media in children aged <2 years following pneumococcal conjugate vaccine introduction in Colombia.在哥伦比亚引入肺炎球菌结合疫苗后，2岁以下儿童全因性肺炎和中耳炎的发病趋势。
Hum Vaccin Immunother. 2021 Apr 3;17(4):1173-1180. doi: 10.1080/21645515.2020.1805990. Epub 2020 Sep 23.
3
Effectiveness of 13-Valent Pneumococcal Conjugate Vaccine Against Invasive Disease Caused by Serotype 3 in Children: A Systematic Review and Meta-analysis of Observational Studies.13 价肺炎球菌结合疫苗预防儿童血清型 3 引起的侵袭性疾病的有效性：系统评价和观察性研究的荟萃分析。
Clin Infect Dis. 2019 May 30;68(12):2135-2143. doi: 10.1093/cid/ciy920.
4
Meeting of the Strategic Advisory Group of Experts on immunization, October 2017 – conclusions and recommendations.免疫战略咨询专家组会议，2017年10月——结论与建议
Wkly Epidemiol Rec. 2017 Dec 1;92(48):729-47.
5
Comparison of the Impact of Pneumococcal Conjugate Vaccine 10 or Pneumococcal Conjugate Vaccine 13 on Invasive Pneumococcal Disease in Equivalent Populations.比较 10 价肺炎球菌结合疫苗与 13 价肺炎球菌结合疫苗对等效人群中侵袭性肺炎球菌病的影响。
Clin Infect Dis. 2017 Nov 13;65(11):1780-1789. doi: 10.1093/cid/cix685.
6
Impact of ten-valent pneumococcal conjugate vaccine on pneumonia in Finnish children in a nation-wide population-based study.在一项基于全国人口的研究中，十价肺炎球菌结合疫苗对芬兰儿童肺炎的影响。
PLoS One. 2017 Mar 1;12(3):e0172690. doi: 10.1371/journal.pone.0172690. eCollection 2017.
7
Impact and Effectiveness of 10 and 13-Valent Pneumococcal Conjugate Vaccines on Hospitalization and Mortality in Children Aged Less than 5 Years in Latin American Countries: A Systematic Review.10价和13价肺炎球菌结合疫苗对拉丁美洲国家5岁以下儿童住院率和死亡率的影响及效果：一项系统评价
PLoS One. 2016 Dec 12;11(12):e0166736. doi: 10.1371/journal.pone.0166736. eCollection 2016.
8
Effectiveness of three pneumococcal conjugate vaccines to prevent invasive pneumococcal disease in Quebec, Canada.三种肺炎球菌结合疫苗预防加拿大魁北克侵袭性肺炎球菌疾病的有效性
Vaccine. 2015 May 28;33(23):2684-9. doi: 10.1016/j.vaccine.2015.04.005. Epub 2015 Apr 15.
9
Impact of ten-valent pneumococcal conjugate vaccination on invasive pneumococcal disease in Finnish children--a population-based study.十价肺炎球菌结合疫苗对芬兰儿童侵袭性肺炎球菌疾病的影响——一项基于人群的研究
PLoS One. 2015 Mar 17;10(3):e0120290. doi: 10.1371/journal.pone.0120290. eCollection 2015.
10
Effectiveness of ten-valent pneumococcal conjugate vaccine against invasive pneumococcal disease in Brazil: a matched case-control study.十价肺炎球菌结合疫苗在巴西预防侵袭性肺炎球菌病的效果：一项匹配病例对照研究。
Lancet Respir Med. 2014 Jun;2(6):464-71. doi: 10.1016/S2213-2600(14)70060-8. Epub 2014 Apr 10.